MET and glioblastoma: Mechanistic findings suggest that overexpression of MET upregulates PD‐L1 and phosphorylates STAT4, and activation of the MET/STAT4/PD‐L1 pathway and upregulation of macrophages predicts poor prognosis in primary GBM patients.